Godrej’s Food and Microbiology lab drives consumer-centric innovation
The functional ingredient contains 65-70 percent hydrolyzed protein for use in meat analogs, in addition to offering a complete amino acid profile
Parabel USA, a producer of plant protein ingredients from water lentils, is preparing for the commercial production of its colorless water lentil hydrolysate ingredient, scheduled for the end of this year.
This product is designed to be an allergen-free substitute for any plant protein used today, such as soy or pea. The functional ingredient contains 65-70 percent hydrolyzed protein for use in meat analogs, in addition to offering a complete amino acid profile. The ingredient is also marketed as an ideal solution in the sports protein market.
“In conjunction with its complete amino acid profile and high digestibility the water lentil hydrolysate will be an easy drop-in solution to everything plant- based – from burgers and sausages to sports nutrition and beverages,” says Anthony Tiarks, CEO of Parabel.
Parabel’s Lentein products are Non-GMO Project Verified and are certified Kosher and Halal. Water lentils (Lemnoideae) are pegged by the company as a sustainable choice for plant-based manufacturers concerned about the food system’s impact on climate change, particularly meat production industries such as the livestock sector.
Innova Market Insights reports that meat substitutes accounted for 11 percent of new meat product launches (meat, poultry and meat substitutes) reported in Europe last year, up from 9 percent in 2013. The global picture shows stronger growth, with 14 percent of meat launches in 2018 being meat alternatives, compared to 6 percent in 2013.
The water lentil hydrolysate is Parabel’s newest addition to its Lentein protein line, which now includes a plant milk, superfood supplement and flour. Parabel is currently finalizing its second water lentil farm, bringing the capacity for Lentein plant protein to 3,500 Metric Tons (MT) per year.
Last August, Parabel received a GRAS (generally recognised as safe) no objections letter from the US Food and Drug Administration for Lentein, and went on to secure distribution deals with Stauber USA and CK Ingredients.